Peel Hunt Ltd (PEEL)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 89.50 |
|---|---|
| 52-week range | 86.00 – 125.00 |
| Return, 1 month / 3 months | +0.0% / −8.7% |
| Return, 1 year / 3 years | −8.9% / +14.5% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 21.3% |
| Worst drawdown (1 year) | -25.3% |
| Average daily value traded | 12.10M GBX |
| Dividend yield | 5.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Peel Hunt is an investment bank based in London that serves companies and institutional investors. It provides corporate broking and advisory services, helping businesses raise capital and manage their relationships with shareholders. Its research and execution arm offers institutional investors analysis and trading services across British equities. The firm works mainly with corporate clients and fund managers, acting as an intermediary between companies seeking finance and the investors who provide it.
The shares are listed on the London Exchange in UK under the code PEEL, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Peel Hunt Ltd (PEEL) trades on the London Exchange in UK. It last closed at GBX 89.50 on 22 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 2,162 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.9% and over the last three months it fell 8.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 29 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.6% | ||
| From 52-week high | -28.4% | ||
| Momentum | 31 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.7% | ||
| 6-month return | -10.2% | ||
| 12-month return, skipping the last month | -8.9% | ||
| Stability (higher is calmer) | 72 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.3% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 12.10M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 5.5% | ||
| Years with dividends | 2 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | −8.7% |
| 6 months | −10.2% |
| 1 year | −8.9% |
| 3 years | +14.5% |
| 5 years | −58.2% |
Signals
| 50-day / 200-day average | 91.18 / 97.92 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.97 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Jun 2026 | GBP 0.0490 |
| 16 Jun 2022 | GBP 0.0310 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.